Apitegromab
Scholar Rock's myostatin-blocking antibody. Myostatin is the signal telling your body to limit muscle — block it, and the hope is you keep muscle you'd otherwise lose. Being tested alongside GLP-1 drugs so the weight you drop is fat, not muscle.
What people claim
Take it with a GLP-1 and your body keeps the muscle while burning the fat — the missing half of the weight-loss stack.
Human evidence
Genuinely real human data, unusual for anything discussed in muscle-preservation circles. Apitegromab has been through years of human trials in spinal muscular atrophy — including a positive phase 3 (SAPPHIRE) — which is where most of its human safety record comes from. For the use everyone here cares about, the phase 2 EMBRAZE trial paired it with tirzepatide in adults with obesity: similar total weight loss, with substantially less of that loss coming from lean mass. Phase 2 is promising, not proof — the bigger trials are what settle it.
Animal evidence
Myostatin inhibition has decades of striking animal biology behind it — famously double-muscled cattle and 'mighty mice' with natural myostatin mutations. That biology is why drug companies keep coming back to this target.
Risk flags
- Long-term effects unknown
- Unregulated / grey-market supply
- Purity & quality unknowable
- Banned in tested sport (WADA)
Regulatory status
US: Investigational. NOT FDA-approved for anything as of early 2026 — its SMA application hit a manufacturing-related delay, and the weight-loss use is still in trials.
UK: Investigational; no MHRA authorisation.
Everyone's an expert
Who says what
Gym Bros Say
"This is the cheat code — GLP-1 melts the fat, myostatin blocker guards the muscle. The final boss of body recomp."
Reddit Says
GLP-1 subs are extremely excited about EMBRAZE, with a running debate about whether lean-mass preservation on a DEXA scan translates into actual strength and function.
Big Pharma Says
Scholar Rock is openly positioning apitegromab as the muscle-preservation partner for the GLP-1 era — the EMBRAZE trial with tirzepatide is exactly that play.
Science Actually Says
Grade B: real human trials across two indications, including a positive phase 3 in SMA and an encouraging phase 2 in obesity. The muscle-preservation-during-weight-loss claim specifically rests on phase 2 data — genuinely promising, not yet settled.
PeptideStackers Says
One of the three antibodies we think could genuinely change the fat-loss game. Also completely unobtainable legitimately right now — and a monoclonal antibody is not something a research-chem site can actually make, so treat any vial claiming to be this as fiction.
Honesty section
What we still don't know
- ?Whether the preserved lean mass means preserved strength and function, not just a better DEXA readout.
- ?Long-term safety of chronic myostatin blockade in otherwise healthy adults.
- ?Whether the phase 2 obesity result holds up in larger, longer trials.
- ?What happens to the preserved muscle after both drugs stop.
Real questions people ask
FAQ
- Is apitegromab approved?
- No. As of early 2026 it isn't approved for anything. Its lead application (for spinal muscular atrophy) was delayed by a manufacturing issue, and the obesity/muscle-preservation use is still in trials.
- Can you buy apitegromab?
- Not legitimately. And unlike small peptides, a monoclonal antibody requires living-cell bioreactor manufacturing and a cold chain — a grey-market vial labelled 'apitegromab' is almost certainly not a functioning antibody. This is the rare compound where the fakes aren't just risky, they're near-guaranteed.
- Does apitegromab burn fat?
- No — it's not a fat-loss drug. The idea is that it protects muscle while something else (a GLP-1 drug, a calorie deficit) drives the fat loss. That's why it's being trialled alongside tirzepatide, not instead of it.
Before you do anything
Questions to ask a qualified professional
- 01Is any approved, monitored option available to me for preserving muscle during weight loss (protein intake, resistance training, supervised care)?
- 02How would a doctor even verify that an unapproved antibody product is real?
- 03If this gets approved, what monitoring would come with it?